Increased plasma cholesterol and decreased body lipid levels in wistar rats following pirinixil (BR 931) treatment
- 1 June 1979
- journal article
- research article
- Published by Elsevier in Pharmacological Research Communications
- Vol. 11 (6) , 475-482
- https://doi.org/10.1016/s0031-6989(79)80019-3
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.Heart, 1978
- Effect of wy-14,643 on cholesterol metabolism in normal and hypercholesterolemic ratsAtherosclerosis, 1978
- Pharmacological profile of BR-931, a new hypolipidemic agent that increases high-density lipoproteinsAtherosclerosis, 1978
- The effects of tiadenol, clofibrate and clofibride on bile composition in the ratEuropean Journal of Pharmacology, 1977
- Differential effect of clofibrate on hepatic drug oxidation and cholesterol 7α-hydroxylationBiochemical Pharmacology, 1976
- Hepatic Peroxisome Proliferation: Induction by Two Novel Compounds Structurally Unrelated to ClofibrateScience, 1975
- Oxidation of cholesterol-26-C14 by rat liver mitochondria: effect of nicotinic acidJournal of Lipid Research, 1960
- Detection of steroids in paper chromatographyArchives of Biochemistry and Biophysics, 1952